Stage D prostatic carcinoma Survival rate in relapsed patients following new forms of palliation
| Autor: | Claude Merrin, Arnold Mittelman, K. Welvaart, Gerald P. Murphy |
|---|---|
| Rok vydání: | 1974 |
| Předmět: |
Male
medicine.medical_specialty Hypophysectomy Estranes Urology medicine.medical_treatment Organophosphorus Compounds Prostate medicine Carcinoma Humans Neoplasm Metastasis Stage (cooking) Survival rate Chemotherapy business.industry Adrenalectomy Palliative Care Prostatic Neoplasms medicine.disease Surgery medicine.anatomical_structure Nitrogen Mustard Compounds Hormonal therapy Carbamates business |
| Zdroj: | Urology. 4:283-286 |
| ISSN: | 0090-4295 |
| DOI: | 10.1016/0090-4295(74)90378-1 |
| Popis: | Patients with progressive Stage D carcinoma of the prostate resistant to conventional endocrine therapy were evaluated for their symptomatic response to bilateral adrenalectomy, hypophysectomy, combination hypophysectomy and adrenalectomy, or chemotherapy with a new oral steroidal-alkylating agent, Estracyt (estramustine phosphate). Good, long-term palliative responses were achieved with bilateral adrenalectomy, hypophysectomy, and Estracyt. Because of its ease of administration, effectiveness, and lack of toxicity, oral Estracyt may be considered the method of choice in some cases for failures following conventional hormonal therapy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|